Candel Therapeutics Inc.

NASDAQ: CADL · Real-Time Price · USD
6.05
0.01 (0.17%)
At close: Aug 15, 2025, 3:59 PM
6.10
0.74%
After-hours: Aug 15, 2025, 07:51 PM EDT

Candel Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-4.98 -1.12 -18 -6.2
PEG Ratio
-0.15 -0.00 0.20 -0.91
PS Ratio
n/a n/a 412.75 1.79K
PB Ratio
4.15 3.34 -0.52 3.50
P/FCF Ratio
-10.17 -1.23 -1.58 -9.33
P/OCF Ratio
-10.17 -1.24 -1.64 -10.1
OCF/S Ratio
n/a n/a -251.35 -177.74
Debt / Equity Ratio
0.20 1.79 -0.23 0.01
Quick Ratio
2.77 2.59 12.81 15.84
Current Ratio
2.77 2.59 12.81 15.84
Asset Turnover
n/a n/a 0.00 0.00
Interest Coverage
-15.97 -74.69 -20.33 -485.4
Return on Equity
-0.83 -2.98 0.03 -0.56
Return on Assets
-0.52 -0.92 -0.04 -0.41
Return on Invested Capital
-0.42 -1.05 -0.07 -0.31
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a -6.9 -0.86
Net Profit Margin
n/a n/a -22.93 -289.42
Pretax Profit Margin
n/a n/a -150.35 -288.99
Operating Profit Margin
n/a n/a -277.78 -205.81
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a -138.54 -203.95